Clinical Audit of Denosumab Biosimilar for Aggressive GCT of Bone: A Tertiary Care Center Retrospective Analysis
Our findings suggest that this treatment regimen can significantly improve outcomes for patients with aggressive GCTB, aiding orthopaedic oncologists in managing these challenging cases more effectively.
Authors
- Kumar Vineet (ORCID: https://orcid.org/0000-0002-8077-1299)
- Randeep Singh (ORCID: https://orcid.org/0000-0003-2371-4148)
- Saravana Kumar Jagannathan
Institutions
- Homi Bhabha National Institute (IN)
- Tata Memorial Hospital (IN)
Publication Details
- Journal
- South Asian Journal of Cancer
- Published
- 2025-04-23
- DOI
- https://doi.org/10.1055/s-0045-1808094
- Citations
- 1
- Primary Topic
- Bone Tumor Diagnosis and Treatments
- Type
- article
- Field-Weighted Citation Impact
- 1.67